Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Has results × trastuzumab duocarmazine × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cisplatin 186 Carboplatin 181 Paclitaxel 175 Docetaxel 143 Cyclophosphamide 130 Dexamethasone 117 Doxorubicin 104 pembrolizumab 103 Bevacizumab 103 Gemcitabine 102 Rituximab 96 Prednisone 88 Fluorouracil 86 Pemetrexed 81 Radiotherapy 76 Vincristine 72 Etoposide 72 Capecitabine 69 Nivolumab 68 Trastuzumab 67 Leucovorin 64 Cytarabine 57 Methotrexate 52 Oxaliplatin 49 atezolizumab 47 Lenalidomide 43 Ipilimumab 40 Filgrastim 40 Bortezomib 39 Sorafenib 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03262935 2023-10-19

TULIP

Byondis B.V.

Phase 3 Completed

437 enrolled 17 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡